Navigation Links
Inquiry into Past NHS Treatment Disaster

Bereaved families of persons infected with deadly viruses such as HIV and Hepatitis C decades back, will now get a chance to understand how. //

An independent inquiry is soon to be launched into the contracting of these deadly infections by almost 2000 hemophilia patients, via blood transfusions, in what is acknowledged as the biggest treatment blunder in the history of UK’s National Health Services.

The incident took place in the late 70s and early 80s where out of 4,670 hemophiliacs who received transfusions with donated blood and blood products and exposed to hepatitis C, 1,243 were also exposed to HIV.

Unfortunately, despite improvements in treatment for both viruses, only 2,552 patients with hepatitis C and just 361 with HIV are alive today.

Says Labor MP Lord Peter Archer, who is heading the inquiry: “The purpose of the inquiry is to unravel the facts, so far as we are able, and to point to the lessons that may be learnt.

“ Its impact will, however, depend crucially on the public perception of its value and we shall endeavor to make it a report worthy of high regard. Hopefully our findings may help to restore public confidence in the future treatment of patients.

"We trust it will also help those afflicted and bereaved to come to terms with the tragedy - knowing much more of how it came about”, he added.

The events, which took place between the early 1970s and the mid 1980s, have been described by fertility expert Lord Winston as "the worst treatment disaster in the history of the national health service".

Labor peer Lord Alf Morris, Britain's first minister for disabled people and the present president of the all-party parliamentary group on hemophilia, has been leading the campaign on the patients' behalf.

Hemophilia is a disorder where the blood takes longer time to clot due to the absence or limited amount of one of the proteins essential to clotting.

Former ways of treatment were the transfusions of blood or blood products from pooled blood plasma collections of various donors.

Due the risks of transmission of blood -borne viruses, recent methods are the use of artificially created such proteins.

The Hemophilia Society of UK has welcomed the inquiry.
NN
'"/>




Related medicine news :

1. Kerr Discourages Transfusion Hepatitis Inquiry
2. Inquiry Led In To the Hepatitis B Infection in the Hospitals
3. Advances in Treatment of Cataracts
4. Recommendations for Treatment of Blood Pressue
5. Treatment for Menieres disease
6. Treatment for pre-menstrual syndrome is ineffective
7. Better Treatment for obesity
8. Gene Treatment for Heart Disease
9. More People Seeking Treatment for Depression
10. Focused Treatment For Childhood Cancer
11. Inadequate Drug Treatment For Youth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... ... July 27, 2017 , ... Standard Process is ushering in a new era ... North Carolina Research Campus (NCRC) in Kannapolis, North Carolina and by announcing a new ... fall of this year, occupying over 10,000 square feet on the first floor of ...
(Date:7/27/2017)... ... 2017 , ... For bicycling enthusiasts around the globe, Germany's famous Rad am ... against a backdrop of tree-lined hills at the Nürburgring, a Formula One arena known ... Ring consists of some 73 curves, stretching out over more than 500 meters of ...
(Date:7/27/2017)... (PRWEB) , ... July 28, 2017 , ... ... Syngenta on an upcoming episode of the award-winning television series, American Famer, scheduled ... on RFD-TV. , Syngenta is dedicated to helping humanity face its toughest ...
(Date:7/27/2017)... OH (PRWEB) , ... July 27, 2017 , ... ... Electronic Visit Verification to State Medicaid programs, Managed Care Organizations and Home Care ... 2017. , The MEDsys platform, VinCENT, provides technology solutions to over 1,000 agencies ...
(Date:7/27/2017)... ... 2017 , ... GAFFEY Healthcare, a leading provider of revenue ... Vice President of Revenue Cycle Business Services and Suzanne Dusak to Vice President ... officer (CEO). , Elrene has been with company since Oct 2014 and previously ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 2017 Zymo Research Corp., also known as ,The Epigenetics Company, ... aging in a precise manner using the myDNAge ™ test. Based ... professor of human genetics and biostatistics at the David Geffen School ... , Zymo Research,s proprietary DNAge ™ technology is used to analyze ... ...
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... , July 10, 2017 Locus Biosciences ... Note to support the development of CRISPR-Cas3 antimicrobial therapeutics. ... Limited, a leading Chinese Internet services provider, and joined ... advance multiple infectious disease product programs targeting antibiotic resistant ... Founded by Dr. Rodolphe Barrangou ...
Breaking Medicine Technology: